Amwill Health Care Limited opens its IPO for subscription on February 5th 2025.
The IPO is a book built offer with a total issue size of 54,03,600 Equity Shares at a price range of Rs. 105 to Rs. 111 per equity share. The IPO is scheduled to be listed on SME platform of Bombay Stock Exchange on 12th February, 2025.
Amwill Health Care Limited is a derma-cosmetic company that focuses on production of dermatological, cosmeceutical and aesthetical products that provide solutions to generic and specific dermatological disorders.
Since the Incorporation, the company has developed many new skin care, hair care and body care products like hydra cream, ozederm cream, depimed ultra cream etc.
It operates through one of the company’s entities, M/s. Amderma Healthcare LLP that acts as a carry forward agent for storing, delivering and distributing of the products to third party agencies or distributors and contract manufacturers. It’s major customer base is situated in Karnataka, Andhra Pradesh and Telangana and aims to create a strong business presence in these states and is further expanding its operations in West Bengal and Orissa.
The company has a strong management team and is focused to grow with the diverse product portfolio and delivery systems.
Details Of The Amwill Health Care Limited IPO?

- Total Issue Size: It provides a total issue size of 54,03,600 equity of Rs 10 face value.
- Fresh Issue Size: It provides a fresh issue size is 44,03,600 equity shares of Rs. 10 face value.
- Offer for sale: 10,00,000 equity shares with a face value of Rs. 10
- Price Range: The bidding ranges from Rs.105 - 111 per share.
- Issue Type: The IPO is Book Built issue type.
- Subscription date: The issue period begins from February 5th 2025 and ends on February 7th 2025.
- Lot size: It is providing a lot size of 1200
- Listing Date: The IPO is going to be listed on 12th February 2025.
- Stock Exchange: The exchange is going to be the SME platform of BSE.
Objectives of the Amwill Health Care Limited IPO
The Company with the help of this IPO seeks to utilize the net proceeds towards meeting working capital, implement better marketing and branding strategies and for general corporate developments.
Also Learn: What is an IPO?
Financial Performance of Amwill Health Care Limited
The table below (in lakhs) stipulates the restated Financial Information of the company over the last 3 fiscal years and up-till September 30, 2024.
Particulars | 30.09.2024 | 31.03.2024 | 31.03.2023 | 31.03. 2022 |
Share Capital | 1,560.00 | 5.00 | 3.00 | 3.00 |
Net Worth | 2,367.52 | 1,715.86 | 460.23 | 148.79 |
Revenue from operations | 2,315.60 | 4,394.83 | 3,016.63 | 2,761.32 |
Profit After Tax | 651.66 | 1,253.63 | 311.44 | 257.37 |
Industry Outlook
The market of beauty and personal care sector that consists of skin care, hair care, oral care, fragrances, and colour cosmetics segments has drastically increased in India with the rapid development of technology and ecommerce platforms like Amazon, Nykaa etc, this market is currently valued at $14 billion.
With the increasing demand of the consumers due to the constant changes to the makeup trends and regimes has given rise to many domestic start-ups and has also attracted global beauty brands to expand in India.
It is projected that this market share will reach US20 billion by 2025, increasing at a CAGR of 25% and the worldwide cosmetics market is predicted to grow at a CAGR of 4.3% and hit US $450 billion by 2025.
There is also constant growth towards sustainable beauty and personal care in India with many new companies and start-ups promoting ayurvedic, herbal products, with the growing population and the robust development of ecommerce platforms and technology, India is projected to be among the top 5 global cosmetic market in terms of revenue by 2025.
Strengths and Risks of Amwill Health Care Limited
Strength:
- The company has high quality development and management team with strong tie-ups with contract manufactures and prototype developers.
- The company has shown significant financial growth over the last three fiscal years with its profit after tax increasing from Rs. 257.37 lakh in 2022 to Rs. 651.66 lakhs in 2024 and Rs. 1,253.63 lakhs as of 30th September, 2024.
- The company since inception has an extensive product portfolio that provides solutions to all kinds of dermatological disorders. It has developed many products to cater the needs of its customers and has created a considerable name in the beauty market.
- The company aims to diversify its product portfolio and enhance its marketing network to build a strong business presence in this sector in the coming years.
IPO Subscription Details
With a fresh issue size of 44,03,600 equity shares and offer for sale of 10,00,000 equity share of face value of Rs. 10 respectively. The lot size is 1200 nos and the bidding ranges from Rs. 105 to Rs. 111 per share. The issue period begins from February 5th 2025 and ends on February 7th 2025 and is scheduled to list on 12th February 2025 on the SME platform of BSE.
Expert Recommendations
The beauty care market has seen drastic growth with the rapid increase of ecommerce in India. There has been rising demand from consumers in this sector due to the constant change in trends and lifestyle.
Many multinational companies have started its expansion in India along with many startups focusing on ayurvedic and sustainable beauty products.
The company has shown healthy profits from the last three fiscal years with its profit after tax increasing from Rs. 257.37 lakh in 2022 to Rs. 651.66 lakhs in 2024 and Rs. 1,253.63 lakhs as of 30th September, 2024 but is also vulnerable due to the growing competition from already well established companies in this sector.
Prospective investors should carefully go through the draft prospectus before investing.
Key Takeaways
The company with the help of this IPO primarily seeks to incorporate marketing strategies to expand its business.
The company has significantly grown in terms of revenue, capital and profit since inception and aims to expand its product portfolio and make a strong business presence in the market.
Prospective investors should weight the company’s risks as outlined in the RHP draft prospectus before proceeding to invest.
Frequently Asked Questions: Amwill Health Care Limited
1. When is the Amwill Health Care Limited IPO being listed?
The IPO is being listed on 12th February on BSE(SME).
2. Is the IPO fairly Priced?
The average price/earning ratio is 35.76 and the bid price is set at Rs.105-111 per share.
3. Where else we can get more information about the Amwill Health Care Limited IPO ?
You can get more information about the IPO on the BSE website.
1. https://www.ibef.org/research/case-study/growth-of-the-cosmetic-indusry-in-india
2. https://www.amwillhealthcare.com/
3. RHP AMWILL
Also Learn About: Ken Enterprises Limited IPO